Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway.
暂无分享,去创建一个
M. Borowiec | H. Maciejewski | D. Appelhans | B. Voit | M. Bryszewska | I. Franiak-Pietryga | K. Ostrowska | M. Misiewicz | Paweł Kowalczyk